Clinical Trials
Impacting the patient journey: From diagnosis to surgical intervention to therapy.
-
Norroy is leading the way in innovative cancer treatmentapproaches.
We are dedicated to improving the quality of life for patients with cancer and rare diseases, placing their needs at the core of everything we do. We are committed to offering patients accessible and clinically efficient treatment options, providing timely choices that support their care journey. To date, we have already benefited hundreds of patients through our therapies.
Norroy clinical trials
Norroy is advancing the forefront of diagnostic and therapeutic nuclear medicine through a series of clinical trials conducted in collaboration with leading top-tier hospitals in China. Some of our products are scheduled to initiate Phase III multicenter clinical trials in the second half of 2025. Please refer to the clinical trials that Norroy has already completed below.
